Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2005 1
2008 1
2009 3
2010 8
2011 7
2012 4
2013 5
2014 5
2015 6
2016 6
2017 16
2018 11
2019 11
2020 28
2021 15
2022 27
2023 25
2024 35
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America.
Bloom MW, Vo JB, Rodgers JE, Ferrari AM, Nohria A, Deswal A, Cheng RK, Kittleson MM, Upshaw JN, Palaskas N, Blaes A, Brown SA, Ky B, Lenihan D, Maurer MS, Fadol A, Skurka K, Cambareri C, Chauhan C, Barac A. Bloom MW, et al. Among authors: blaes a. J Card Fail. 2025 Feb;31(2):415-455. doi: 10.1016/j.cardfail.2024.08.045. Epub 2024 Oct 15. J Card Fail. 2025. PMID: 39419165 Review.
Shared Risk Factors in Cardiovascular Disease and Cancer.
Koene RJ, Prizment AE, Blaes A, Konety SH. Koene RJ, et al. Among authors: blaes a. Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406. Circulation. 2016. PMID: 26976915 Free PMC article. Review.
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. Herrmann J, et al. Among authors: blaes a. Eur Heart J. 2022 Jan 31;43(4):280-299. doi: 10.1093/eurheartj/ehab674. Eur Heart J. 2022. PMID: 34904661 Free PMC article.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Curigliano G, et al. Among authors: blaes a. Ann Oncol. 2020 Feb;31(2):171-190. doi: 10.1016/j.annonc.2019.10.023. Ann Oncol. 2020. PMID: 31959335 Free PMC article.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH; COMET Study Investigators. Hwang ES, et al. JAMA. 2025 Mar 18;333(11):972-980. doi: 10.1001/jama.2024.26698. JAMA. 2025. PMID: 39665585 Free PMC article. Clinical Trial.
Response to Schoormans.
Blaes A, Konety S, Zordoky B. Blaes A, et al. J Natl Cancer Inst. 2021 Feb 1;113(2):214-215. doi: 10.1093/jnci/djaa158. J Natl Cancer Inst. 2021. PMID: 33057689 Free PMC article. No abstract available.
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.
Partridge AH, Hyslop T, Rosenberg SM, Bennett AV, Drier S, Jonsson M, Shimada A, Li Y, Li Y, Lynch T, Frank E, Collyar D, Basila D, Pinto D, Weiss A, Wolf A, Norris K, Witten M, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Darai S, Carey L, Thompson A, Hwang ES; COMET Study Consortium. Partridge AH, et al. JAMA Oncol. 2025 Mar 1;11(3):300-309. doi: 10.1001/jamaoncol.2024.6556. JAMA Oncol. 2025. PMID: 39665588 Clinical Trial.
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).
Huppert LA, Mahtani R, Fisch S, Dempsey N, Premji S, Raimonde A, Jacob S, Quintal L, Melisko M, Chien J, Sandoval A, Carcas L, Ahluwalia M, Harpalani N, Hoppenworth J, Blaes A, Blum K, Kim MO, Idossa D, Rao R, Giridhar KV, Rugo HS. Huppert LA, et al. Among authors: blaes a. NPJ Breast Cancer. 2025 Apr 15;11(1):34. doi: 10.1038/s41523-025-00748-5. NPJ Breast Cancer. 2025. PMID: 40234477 Free PMC article.
Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer Care.
Gupta A, Johnson WV, Henderson NL, Ogunleye OO, Sekar P, George M, Breininger A, Kyle MA, Booth CM, Hanna TP, Rocque GB, Parsons HM, Vogel RI, Blaes AH. Gupta A, et al. Among authors: blaes ah. JAMA Netw Open. 2024 Nov 4;7(11):e2447649. doi: 10.1001/jamanetworkopen.2024.47649. JAMA Netw Open. 2024. PMID: 39602118 Free PMC article.
212 results